Key Insights

Highlights

Treatment Research

3 treatments under study, led by Triamcinolone Acetonide

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total

Not Applicable (1)

Phase 3 (1)

Trial Status

Unknown1

Not Yet Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials

NCT07189572Phase 3Not Yet Recruiting

Intranasal Corticosteroid Spray for Preventing Otitis Media With Effusion After Radiotherapy in Nasopharyngeal Carcinoma

NCT05449184Not ApplicableUnknownPrimary

A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPC

Showing all 2 trials

Research Network

Common Treatments

Triamcinolone Acetonide1
Balloon Eustachian Tuboplasty With Tympanostomy Tube Insertion1
Tympanostomy Tube Insertion1

Active Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1
Sun Yat-Sen University Cancer Center1

Otitis Media With Effusion After Nasopharyngeal Carcinoma